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The recurrent pain of a neuroma following surgical excision and burial of nerve endings can be clinically challenging to
manage. Cryoanalgesia in conjunction with ultrasound guidance was used successfully to manage this type of pain. Furthermore,
ultrasound provided visualization of the cryolesions, as well as the relationships of the ice ball to the surrounding tissue. Following
the completion of the freeze cycle, the tissue can be monitored for return to its usual morphology during the thaw period.
1.Introduction
Cryoanalgesia is a technique intended to provide pain relief
in which low temperatures are used to generate soft tissue
lesions [1]. It was ﬁrst executed by Cooper et al. in 1962 with
an early method that involved a hollow tube with an insu-
lated tip, utilized liquid nitrogen as a coolant and achieved
a temperature of –190◦C[ 2]. Lloyd et al. ﬁrst used the term
“cryoanalgesia” for pain relief in 1976 [3]. They described a
technique in which the exposure of painful tissue to locally
subphysiologic temperatures could produce an eﬀective re-
versible conduction block of peripheral nerves without the
subsequent development of neuralgia. A major limitation in
thecharacterizationofapercutaneouslygeneratedcryolesion
is that the lesion itself cannot be visualized in the closed ap-
plication, and the only means of conﬁrmation of appropriate
probe function is by the use of a thermocouple to monitor
temperature. However, use of the thermocouple does not
provide details of ice ball formation. Modern ultrasound
technique may allow this visual limitation to be overcome
and provide greater ability to assess and even quantify the
dimensionsofacryolesioninrealtimeasitisbeingproduced
to provide a therapeutic endpoint during the cryoablation
procedure.
Conventionally, pain physicians have used anatomical
and ﬂuoroscopic landmarks as well as sensory and motor
stimulation to conﬁrm the proximity of the cryoprobe to a
target nerve. In a consideration of safety, this provides only a
crude avoidance of potentially critical structures such as ad-
jacent critical blood vessels, which may be avoided with ul-
trasonographic guidance. From a therapeutic standpoint, ul-
trasound allows imaging of many peripheral nerves and thus
canprovidevisualconﬁrmationthatacryolesionhasencom-
passed the target nerve and enables spacial adjustments to
be made as necessary. Ultimately, the employment of ultra-
sound guidance will likely increase the therapeutic success
and reduce patient morbidity involved in cryotherapy.
Wedescribeacaseofsuralneuroma,inwhichultrasound
guidance was used to visualize in real time the lesion gen-
erated during a cryotherapy procedure. Although the use of
ultrasound guidance in cryoanalgesia has been described, to
the best of our knowledge the ultrasonographic image of a
cryolesion itself for use in treatment in peripheral nerve
cryotherapy has heretofore not been demonstrated in the
pain medicine literature [4–6].
2.CaseReport
A ﬁfty-seven-year-old male with a past medical history sig-
nificant for asthma and hypertension presented with a chief
complaint of distal left lower extremity pain. At the age of2 Case Reports in Anesthesiology
Figure 1: The blue skin marker demarcates the area of maximum
pain in the hyperpigmented skin graft site of the left lower extrem-
ity.
twenty-one he was struck by a motor vehicle and sustained
multiple fractures as well as a signiﬁcant degloving injury to
his distal left lower extremity. He underwent multiple exten-
sive surgeries involving bone and skin grafts. Approximately
six years prior to presentation at our clinic, he experienced
a considerable exacerbation of his pain symptoms, was di-
agnosed with a sural neuroma, and eventually underwent
surgical excision of the neuroma. The sural nerve endings
were buried deep into the muscle just above the periosteum.
Unfortunately, his pain returned which he described as
burning, shooting, and located over his left lateral leg distal
to the knee extending down to the ankle. The pain was exac-
erbated with palpation, eversion of the foot, and prolonged
standing. He was treated with physical therapy, gabapentin,
amitriptyline, and TENS unit with minimal beneﬁt. At the
time of presentation, he was taking desipramine 25 milli-
grams (mg) nightly and hydrocodone-acetaminophen 5mg/
500mgasneeded,whichalleviatedonlyaportionofhispain.
On examination, he was a well-appearing man in no appar-
ent distress. His left lower extremity distal to the knee re-
vealed skin grafts, scarring, and hyperpigmentation (Figure
1). Hyperalgesia was present over the left lateral leg approxi-
mately halfway between the knee and ankle. This region had
apositive Tinel’s sign overaportion ofthescar.Therewasno
distinct palpable mass. The rest of the standard neurological
examination was within normal limits.
In March of 2007, the patient received an injection of the
suralneuromasitewithlocalanestheticandsteroid.Heexpe-
rienced signiﬁcant relief for only the duration of the local
anesthetic eﬀect. He was then scheduled for cryoneurolysis
of the sural neuroma. Throughout a period of 3 years in our
clinic, he reported excellent relief from cryoneurolysis for 3
months following each serial treatment. In fact, he reports
Figure 2: The cryoprobe was inserted via a 12-gauge angiocatheter
introducer proximal to the skin graft site of the left lower extremity.
The ultrasound probe is being utilized to provide an in-plane
view of the cryoprobe and ice ball location during cryoneurolysis
treatment.
that for a period of approximately 10 weeks following the
procedure, “I forget that I even have a pain in my leg.”
Because of imaging limitations with ﬂuoroscopy, ultra-
sound was used to better characterize the relationship of the
cryoprobe in soft tissues relative to the ﬁbula. The patient
was placed in the right lateral decubitus position, and sterile
prepanddrapewereperformedusingchlorhexidine/alcohol.
Three milliliters (mL) of 1% lidocaine was inﬁltrated subcu-
taneouslyusinga27-gaugeneedleattheentrysiteforthecry-
oprobe located approximately 2 centimeters (cm) proximal
totheskingrafts(Figure 2).Usingan11blade,a3-millimeter
(mm) stab skin incision was made through which a 12-gauge
angiocatherer was inserted into the subcutaneous tissue with
the aid of ultrasound guidance (General Electric Venue 40
ultrasound system and 12L linear probe). Ultrasonographic
examination of the corresponding painful site did not allow
visualization of an apparent sural neuroma. A 14-gauge cry-
oprobe (Wallach WA5000 Painblocker) was inserted through
the 12-gauge angiocatheter upon removal of the needle. Pro-
per sensory stimulation was used to conﬁrm proper place-
ment of the cryoprobe at 125 Hertz (Hz) to reproduce par-
esthesias over the patient’s typical location of pain. The
cryotherapy session consisted of 6 individual cryolesions,
each of 4 minute duration, with a 40-second thaw period
between each lesion.
During the beginning of the procedure, the cryolesion
and cryoprobe were imaged using ultrasound both in-plane
andout-of-planeview.Theproximityofthecryoprobetothe
ﬁbula was easily visualized prior to beginning cryotherapy
(Figure 3). Any apparent vascular structures were readily
avoided during cryoprobe insertion under direct in-plane
ultrasonographic guidance and doppler examination. The
spacial magnitude of the cryolesion relative to the cryoprobe
was easily visualized under real-time ultrasound. The lesion
appeared as an echo-opaque hemisphere with a hyperechoic
rim with a posterior acoustic shadowing (Figure 4). The le-
sion was easily appreciated as increasing in size radially
throughoutthe4-minuteperiodaswellasdecreasingradially
during the 40-second thaw period between lesions. The











Figure 4: Cryolesion (diameter = 0.80cm) at 1 minute and 30
seconds into the freeze cycle. Note the hyperechoic rim with
posterior acoustic shadowing emanating from the tip of the probe.
1.12 at 1.5, 2, 3, and 4 minutes, respectively. The short axis
view conﬁrmed the spherical nature of the lesion at the
tip. The largest ultrasonographically measured cryolesion
was an area of 0.85cm2 and a circumference of 3.28cm, at
4 minutes into freezing cycle (Figure 5). It must be taken
into consideration that because of the posterior acoustic
shadowing cast by the cryolesion, as its radius increases the
dimensions of the posterior portion of the cryolesion must
be approximated for measurement purposes. The cryoprobe
waspositionedsothattheposteriorportionofthecryolesion
would include the periosteum of the lateral mid-ﬁbula where
the symptomatic neuroma was believed to lay. After a 4-
minute cryolesion, the tissue changes were visualized at 50
seconds but then normalized at 2 minutes and 20 seconds
(Figure 6). The patient tolerated the procedure well without
apparent complications. Sequential freezing and thawing
pictures as presented in Figures 3–6.
3. Discussion
Increased utilization of ultrasound is becoming more com-
monplace in both acute and chronic pain therapies. Aside
from oﬀering image guidance, other potential beneﬁts of
ultrasound include decreased radiation exposure, increased
portability, and decreased costs [5]. In this case of recurrent
pain after surgical excision of a neuroma, ultrasound allowed
identiﬁcation of the ice ball in relation to the deep mus-
cle, fascia, and periosteum. Ultrasonographic imaging has













Figure 6: Cryolesion is barely visible at 1 minute and 30 seconds
into the thaw period.
lesions during cryodestruction of liver tumors in the surgical
literature [7]. It follows that the characteristics of an in vivo
soft tissue cryolesion in the extremities can be determined as
well.
The cryolesions of the liver and peripheral soft tissues,
in this case mostly muscle/fascia, exhibited a similar mor-
phology. The hyperechoic rim of the cryolesion has been de-
scribed as a “freeze front” which advances during the freez-
ing cycle and regresses during the thawing cycle [7]. The
surgical literature also provides evidence that the ultrasound
images of cryolesion and the gross macroscopic hepatic cry-
olesion correlate closely in actual size [8]. Previously, the
ultrasonographic cryolesion has been described as a “hemi-
spherical hyperechoic rim with posterior acoustic shadow-
ing”, and this image was readily observed in this case study
[9]. The hyperechoic rim is thought to be a result of in-
creased acoustic impedence at the border between frozen
and unfrozen tissues, which causes ultrasound waves to be
reﬂected back towards the transducer [8]. The posterior
acousticshadowresultsinpartfromthedecreasedportionof
ultrasoundwavesthatiscapableofpassingthoughthefrozen
cryolesion. Following complete thawing of the cryolesion,
no ultrasonographic diﬀerences were appreciated between
tissues that had undergone cryotherapy and those that had
not. This diﬀers from cryotherapy of the liver, where the
liver tissue that had undergone cryotherapy for 22 minutes
at –180◦C remained hypoechoic compared to surrounding
tissues after complete thawing [7, 8].
Several factors contribute to the dimensions of a lesion
generated during cryotherapy. The overall volume of the
cryolesion itself is a function of the duration of the lesioning4 Case Reports in Anesthesiology
application and the temperature achieved during lesioning
that may be hampered by the constant delivery of body heat
by blood vessels or cerebrospinal ﬂuid [10]. In clinical
practice, the upper limit freeze duration is empirically set
at 4 minutes, because little beneﬁt is thought to be derived
from longer durations [11]. The present images do suggest
the majority of the lesion is established during the ﬁrst two
minutes, but continue to expand an additional 2.5mm at the
end of 4 minutes. On the other hand, repeated freeze-and-
thaw cycles have been demonstrated to be associated with
increased volume of the cryolesion [12]. Repeat freeze/thaw
lesions were not evaluated in this report. Moreover, the ther-
apeutic eﬃcacy of the treatment improves as the placement
of the cryoprobe targets more closely the peripheral nerve
[10] .T h i sa l l o w sf o rag r e a t e rl e n g t ho fap e r i p h e r a ln e r v e
to be lesioned, thereby impairing saltatory conduction so as
to prevent pain transmission [13]. In cats it has been de-
termined that a cryolesion of 3–6mm in diameter was neces-
sary to prevent saltatory conduction [13]. While this agrees
with prior clinical reports [14], the estimations in this study
are nearly twice as large in diameter. This disparity may be
basedonthesizeoftheprobe,diﬀerencesincryodevices,and
the surrounding tissue milieu. In any event, a larger lesion
would be preferable for ensuring an ice ball has interacted
with suﬃcient length of the target nerve. This feature is par-
ticularly useful when target nerves are not readily visualized
as in this case.
In usual clinical practice, an adequate thawing interval
following a cryolesion is desirable. This is because if the
cryoprobe is moved before complete thawing has occurred,
damage may transpire to surrounding tissues that remain
adherent to the cryoprobe while frozen. A time period
ranging from 20th–40 seconds for a thaw interval prior to
repositioning the cryoprobe before starting the next freeze
cycle has been used clinically for years without reported ad-
verse events [10]. After a 4-minute cryolesion, tissue changes
were very apparent at 50 seconds and did not normalize until
140 seconds later. Though ultrasonographic data would
suggest a 140-second thaw interval after a 4-minute cryol-
esion, there have been no adverse reports using the shorter
aforementioned intervals. Therefore it is diﬃcult to recom-
mend increasing the time for thawing, but warrants further
investigation.
4. Conclusions
Ultrasoundtechniques oﬀervaluable guidance of cryoprobes
into deep soft tissue that is in close proximity to periosteum
where transposed nerve endings lie. Furthermore, ultra-
sound can be useful in characterizing the dimensions of ul-
trasound lesions and their relationships to surrounding
tissues. Lastly, this imaging modality can also be used to
determine when the tissue following a cryolesion returns to
its usual morphology.
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